Clinical trial
Assessment of Biomarker Profile in Diabetic Macular Edema in Response to Treatment With Intravitreal Aflibercept
NCT03297684 is registered in ClinicalTrials.gov with Advanced Eye Research Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Biomarker Profile in Diabetic Macular Edema in Response to Treatment With Intravitreal Aflibercept
- Lead sponsor
- Advanced Eye Research Associates
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 11, 2018
- Completion date
- December 31, 2022
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema